Quote:Trump’s Approval Rating Hits Rock Bottom Ahead Of James Comey’s Testimony
By Sean Colarossi on Wed, Jun 7th, 2017 at 8:37 pm
The poll also found that a staggering 60 percent of Americans believe the president's relationship with Moscow is either "illegal" or "unethical."
![]()
As James Comey prepares to testify before the Senate Intelligence Committee on Thursday, Donald Trump’s approval rating is crashing to the ground.
According to a new Quinnipiac University poll released on Wednesday, a disastrous 34 percent of the country – a record low for this president – approves of the job he has done so far. A strong majority, 57 percent, disapprove of his job performance.
The numbers:
AKA: WTF is wrong with the 29%-40%?!
![]()
More key findings from the poll:
•68 – 29 percent that Trump is not level-headed
•59 – 36 percent that he is not honest
•58 – 39 percent that he does not have good leadership skills
•58 – 40 percent that he does not care about average American
•64 – 33 percent that he does not share their values
•62 – 32 percent disapprove of Trump’s decision to withdraw from the Paris agreement
Unsurprisingly, one of the top issues on the minds of voters is the ongoing investigation into Trump’s ties to Russia and whether his campaign colluded with the Russians to swing the election in his favor.
According to the poll, a staggering 60 percent of respondents said that the president’s relationship with Moscow is either “illegal” or “unethical.”
The same applies to those who work for the president, Quinnipiac noted: “President Trump’s campaign advisors did something illegal in dealing with Russia, 40 percent of voters say, as 25 percent say they did something unethical but not illegal and 24 percent say they did nothing wrong.”
The Russia scandal is, indeed, a cloud over the Trump administration, and Comey’s testimony – if his opening statement was any indication – will only make that cloud bigger and darker once the former FBI director makes the damning claims under oath.
With or without tomorrow’s testimony, however, the American people may have already tuned this president out and are simply counting down the days until they can vote him out of office.
Trump’s Approval Rating Hits Rock Bottom Ahead Of James
Top 10 Most Recent News Articles
China Automotive Systems Hits Milestone with ASPICE 4.0 CL2
An Automotive Feat in R&D Now here's a story that should make waves across the automotive sector. China Automotive Systems, Inc. (NASDAQ: CAAS), a titan of power steering development in China, has nailed it by meeting the ASPICE 4.0 Capability Level 2. That's a big one, folks. Verified by a partnership between a European automaker and UL, this achievement is no fluke....
Continue Reading
OMLYCLO Shakes Up U.S. Biologic Market as Key Player
Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...
Continue Reading
#L.A. Rising Podcast: From Fires to International Fame
From Ashes to Airwaves Gritty stories of survival often cut deeper than any wonky industry analysis or corporate earnings report. When you've been through the wringer and come out the other side, that experience sticks with you—and for Kim S. Marshall, it ignited something personal yet universal with the #L.A. Rising podcast. Emerging from the 2025 L.A. fires, this...
Continue Reading
Christmas Injury Lawyers Unveils SC Knowledge Center
In the world of legal labyrinths, sometimes you just need a guiding light, especially following a car accident. That's where the freshly launched South Carolina Car Accident Law Knowledge Center steps in. It’s no magic wand, but Christmas Injury Lawyers are certainly trying to cut the chaos. This online hub covers more ground than a small library, boasting 40 guides...
Continue Reading
Travelers Turn to Direct Booking Amid Cost Surge
Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...
Continue Reading
Dan Brown Joins Guidewire: Big Moves in P&C Software
Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...
Continue Reading
Event Industry Power 50 Voting Surge Ahead of Close
An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....
Continue Reading
ProClad Unveils Innovative Hybrid 2.0 Cookware
Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...
Continue Reading
TRIMAX Poised to Meet AI-Driven Power Challenges
TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...
Continue Reading
Palm Beach Royals Boost Pickleball's Popularity Surge
A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...
Continue ReadingTop 5 Most Recently Viewed Articles
Ascletis Kicks Off Phase III Trials for Oral GLP-1 Drug
Dose One: A Step Closer to an Oral Obesity Treatment August 30, 2026, marks a pivotal moment for Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") as they announce the first patient dosed in their global phase III clinical trial of ASC30. This little pill might pack a punch, tackling obesity—a beast of a challenge that's battering waistlines globally. So what's the big deal...
Continue Reading
Biodesix and APAPP Team Up for Innovative Lung Cancer Education
Collaboration to Enhance Lung Cancer Care Biodesix, Inc. (Nasdaq: BDSX), a prominent name in the diagnostic solutions sector, has announced an exciting new partnership with the Association of Pulmonary Advanced Practice Providers (APAPP). This collaboration aims to roll out comprehensive educational programs designed specifically for Advanced Practice Providers (APPs),...
Continue Reading
Westinghouse's New Contract Propels AP1000 Reactor Feasibility
Westinghouse's Strategic Contract with GEN energija Westinghouse Electric Company announced an exciting partnership with Slovenia’s state-owned power firm GEN energija. The duo aims to conduct a comprehensive Technical Feasibility Study (TFS) focused on the deployment of the AP1000 reactor, a pivotal part of Slovenia's nuclear new-build strategy. Collaborating alongside...
Continue Reading
AbbVie Enhances Psychiatry Pipeline with Gilgamesh Acquisition
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin AbbVie (NYSE: ABBV) has successfully finalized its acquisition of Gilgamesh Pharmaceuticals' lead investigational compound, bretisilocin. This strategic acquisition strengthens AbbVie's commitment to pioneering innovations in psychiatric treatments. Expanding the Psychiatry Pipeline The acquisition of...
Continue Reading
Automotive Wiring Harness Market Poised for Growth
Market Projections and Growth Trajectory Roll up your sleeves, folks, because the automotive wiring harness market is gearing up for some shifts. Aiming to expand from $42.95 billion in 2026 to a robust $49.29 billion by 2033, the projected CAGR clocks in at a humble 2%, but don’t be fooled—there’s more beneath the surface here that’s worth a seasoned glance. BEV...
Continue Reading